Lila Bio wins $3.65M NIH SBIR grant to develop AI-designed protein therapy for pulmonary hypertension

Lila Bio received a $3.65 million NIH SBIR grant to develop AI-designed, long-acting injectable protein therapies that aim to modify the underlying disease in pulmonary hypertension; initial work is in lab and animal testing with further studies planned using patient lung tissue.

More: Best Technologies, Off Sand Hill

No comments yet.